Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Kesimpta


Contraindicated

Contraindicated
Kesimpta :
Type Medicine Authorised
Originator Biotech (Kesimpta)
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L04AA

Your comment will appear shortly after approval

Kesimpta :

Revision Date : 06/04/2021


Effect Frequency
Blood immunoglobulin M decreased Common
Injection site reaction Very Common
Oral herpes Common
Upper respiratory tract infection Very Common
Urinary tract infection Very Common

Different Units By MoH Code

Revision Date : 24/03/2022

Revision Date : 24/03/2022

Kesimpta  MoH 10677 :
Form Solution for injection
Packaging Pre-filled pen
Package Size 1x0.4ml
Package Content 1 single-use glass syringe, equipped with a stainless steel needle, a plunger stopper and a rigid needle shield. The syringe is assembled into an auto-injector
Strength 20mg
Storage Condition 2-8°C Do not freeze
Public Price 1583534 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 153320/1
Submission date 23/10/2020
Registration Year 29/09/2021


Price Comparison

● Country: Lebanon
● Form: Solution for injection
● Package Size: 1x0.4ml
● Public Price: 1583534 LBP ( 1,583,534.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1583534 LBP ( 1,583,534.00 LBP )
● Pricing Date: 10/01/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Multiple sclerosis : (Adults)
● Cost/Unit: 1583534 LBP ( 1,583,534.00 LBP )
● Cost/Day: 1583534 LBP ( 1,583,534.00 LBP )
● Cost/Month: 1583534 LBP ( 1,583,534.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info